These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

242 related items for PubMed ID: 26872077

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. A randomized placebo-controlled polysomnographic study of eszopiclone in Japanese patients with primary insomnia.
    Uchimura N, Kamijo A, Kuwahara H, Uchiyama M, Shimizu T, Chiba S, Inoue Y.
    Sleep Med; 2012 Dec; 13(10):1247-53. PubMed ID: 23063301
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Eszopiclone coadministered with escitalopram in patients with insomnia and comorbid generalized anxiety disorder.
    Pollack M, Kinrys G, Krystal A, McCall WV, Roth T, Schaefer K, Rubens R, Roach J, Huang H, Krishnan R.
    Arch Gen Psychiatry; 2008 May; 65(5):551-62. PubMed ID: 18458207
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Efficacy of treatment of insomnia in migraineurs with eszopiclone (Lunesta®) and its effect on total sleep time, headache frequency, and daytime functioning: A randomized, double-blind, placebo-controlled, parallel-group, pilot study.
    Spierings EL, McAllister PJ, Bilchik TR.
    Cranio; 2015 Apr; 33(2):115-21. PubMed ID: 25323219
    [Abstract] [Full Text] [Related]

  • 8. A randomized, double-blind, placebo-controlled trial of eszopiclone for the treatment of insomnia in patients with chronic low back pain.
    Goforth HW, Preud'homme XA, Krystal AD.
    Sleep; 2014 Jun 01; 37(6):1053-60. PubMed ID: 24882900
    [Abstract] [Full Text] [Related]

  • 9. Eszopiclone, a nonbenzodiazepine sedative-hypnotic agent for the treatment of transient and chronic insomnia.
    Najib J.
    Clin Ther; 2006 Apr 01; 28(4):491-516. PubMed ID: 16750462
    [Abstract] [Full Text] [Related]

  • 10. A 12-week, randomized, double-blind, placebo-controlled study evaluating the effect of eszopiclone 2 mg on sleep/wake function in older adults with primary and comorbid insomnia.
    Ancoli-Israel S, Krystal AD, McCall WV, Schaefer K, Wilson A, Claus R, Rubens R, Roth T.
    Sleep; 2010 Feb 01; 33(2):225-34. PubMed ID: 20175406
    [Abstract] [Full Text] [Related]

  • 11. Eszopiclone for the treatment of posttraumatic stress disorder and associated insomnia: a randomized, double-blind, placebo-controlled trial.
    Pollack MH, Hoge EA, Worthington JJ, Moshier SJ, Wechsler RS, Brandes M, Simon NM.
    J Clin Psychiatry; 2011 Jul 01; 72(7):892-7. PubMed ID: 21367352
    [Abstract] [Full Text] [Related]

  • 12. Eszopiclone for the treatment of primary insomnia: a systematic review and meta-analysis of double-blind, randomized, placebo-controlled trials.
    Liang L, Huang Y, Xu R, Wei Y, Xiao L, Wang G.
    Sleep Med; 2019 Oct 01; 62():6-13. PubMed ID: 31518944
    [Abstract] [Full Text] [Related]

  • 13. The impact of eszopiclone on sleep and cognition in patients with schizophrenia and insomnia: a double-blind, randomized, placebo-controlled trial.
    Tek C, Palmese LB, Krystal AD, Srihari VH, DeGeorge PC, Reutenauer EL, Guloksuz S.
    Schizophr Res; 2014 Dec 01; 160(1-3):180-5. PubMed ID: 25454802
    [Abstract] [Full Text] [Related]

  • 14. A 2-week efficacy and safety study of eszopiclone in elderly patients with primary insomnia.
    Scharf M, Erman M, Rosenberg R, Seiden D, McCall WV, Amato D, Wessel TC.
    Sleep; 2005 Jun 01; 28(6):720-7. PubMed ID: 16477959
    [Abstract] [Full Text] [Related]

  • 15. Cost-effectiveness of eszopiclone for the treatment of adults with primary chronic insomnia.
    Snedecor SJ, Botteman MF, Bojke C, Schaefer K, Barry N, Pickard AS.
    Sleep; 2009 Jun 01; 32(6):817-24. PubMed ID: 19544759
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Efficacy and safety of eszopiclone across 6-weeks of treatment for primary insomnia.
    Zammit GK, McNabb LJ, Caron J, Amato DA, Roth T.
    Curr Med Res Opin; 2004 Dec 01; 20(12):1979-91. PubMed ID: 15701215
    [Abstract] [Full Text] [Related]

  • 19. Next-day cognition, psychomotor function, and driving-related skills following nighttime administration of eszopiclone.
    Boyle J, Trick L, Johnsen S, Roach J, Rubens R.
    Hum Psychopharmacol; 2008 Jul 01; 23(5):385-97. PubMed ID: 18350566
    [Abstract] [Full Text] [Related]

  • 20. Cognitive behavioral therapy vs zopiclone for treatment of chronic primary insomnia in older adults: a randomized controlled trial.
    Sivertsen B, Omvik S, Pallesen S, Bjorvatn B, Havik OE, Kvale G, Nielsen GH, Nordhus IH.
    JAMA; 2006 Jun 28; 295(24):2851-8. PubMed ID: 16804151
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.